Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
Emergency War Surgery
Second United States Revision of The Emergency War Surgery NATO Handbook
United States Department of Defense

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

Emergency War Surgery NATO Handbook: Part III: General Considerations of Wound Management: Chapter XVII: Crush Injury

General Management

United States Department of Defense


Intravenous therapy should be initiated immediately after extrication or even, when possible, while the casualty is still trapped. Glucose-saline is the solution of choice; however, Ringer's solution may be used. The early objective is to achieve a constant diuresis of at least 300 cc's per hour with a urine pH of greater than 6.5. An indwelling urinary catheter is inserted. A central venous or pulmonary artery wedge pressure catheter should be utilized to guide fluid infusion and reliably monitor central pressures.

  1. In the presence of an appropriate urinary response, crystalloid solution is administered at the rate of 500 cc/hour. Bicarbonate, 44.5 mEq, is added to the crystalloid solution every other hour.

  2. Urine volume and pH are monitored hourly.

  3. Serum electrolytes, osmolality, and arterial blood gasses are evaluated at six hour intervals.

If the urinary volume is less than 300 cc per hour, mannitol. (1.0 g per kilogram body weight) should be given intravenously. If the arterial pH reaches 7.45 or the urine pH is below 6.5, 250 mg acetazolamide should be given intravenously. This therapy should continue until myoglobin disappears from the urine. It usually takes about 60 hours to achieve this goal.

The earlier one starts intravenous therapy, the better the chance of preventing acute renal failure. When fluid therapy is delayed for six hours following, extrication, acute renal failure is almost assured. If the desired urinary output cannot be achieved, the use of diuretics, preferably furosemide, should be considered. The majority of crush injury victims who do not receive intravenous therapy early enough and who do not respond to enforced alkaline diuresis go on to develop renal failure and the requirement for hemodialysis. If renal failure develops, prompt reduction in fluid administration is indicated.

Infection, which contributes to the development of acute renal failure, should be prevented by all possible means. Wide-spectrum antibiotics, including agents which are effective against anaerobic microorganisms, are indicated. Tetanus toxoid should be given according to the casualty's state of immunization.

The clinical features of crush syndrome may not become evident until just before the patient is to be evacuated on the basis' of his other injuries. If renal insufficiency seems to be developin& the patient should be evacuated, as soon as the other injuries permit, to a medical facility that is capable of monitoring and treating the condition with renal dialysis.

 

 


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products

 

 

Advertise on this site